Skip to main content
SpringerLink
Log in
Book cover

Stroke Genetics pp 127–146Cite as

Genetics of Sickle Cell Disease and Stroke

  • Chapter
  • First Online:

  • 1362 Accesses

Abstract

Sickle cell disease is a common worldwide disorder that can lead to stroke in affected individuals. This chapter describes the epidemiology, pathophysiology, and genetics that contribute to the onset of this disorder. Evidence-based treatment recommendations are also given.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Benz Edward J. Chapter 99. Disorders of hemoglobin (chapter). In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine. McGraw-Hill Professional; 17 edition (March 6, 2008). http://www.accessmedicine.com/content.aspx?aID=2868933

  2. Taylor 6th JG, Tang DC, Savage SA, Leitman SF, Heller SI, Serjeant GR, Rodgers GP, Chanock SJ. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood. 2002;100:4303–9.

    Article  PubMed  CAS  Google Scholar 

  3. Asare K, Gee BE, Stiles JK, Wilson NO, Driss A, Quarshie A, Adams RJ, Kutlar A, Hibbert JM. Plasma interleukin-1 beta concentration is associated with stroke in sickle cell disease. Cytokine. 2010;49:39–44.

    Article  PubMed  CAS  Google Scholar 

  4. Chang Milbauer L, Wei P, Enenstein J, Jiang A, Hillery CA, Scott JP, Nelson SC, Bodempudi V, Topper JN, Yang RB, Hirsch B, Pan W, Hebbel RP. Genetic endothelial biology of sickle stroke risk. Blood. 2008;111(7):3872–9.

    Article  PubMed  Google Scholar 

  5. Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114(25):5117–25.

    Article  PubMed  CAS  Google Scholar 

  6. Meschia JF, Pankratz VS. Defining stroke risks in sickle cell anemia. Nat Genet. 2005;37(4):340–1.

    Article  PubMed  CAS  Google Scholar 

  7. Roberts L, O’Driscoll S, Dick MC, Height SE, Deane C, Goss DE, Pohl K, Rees DC. Stroke prevention in the young child with sickle cell anaemia. Ann Hematol. 2009;88:943–6.

    Article  PubMed  Google Scholar 

  8. Melo HA, Barreto-Filho JA, Prado RC, Cipolotti R. Transcranial Doppler in sickle cell anaemia: Evaluation of brain blood flow parameters in children of Aracaju, Northeast-Brazil. Arq Neuropsiquiatr. 2008;66(2B):360–4.

    Article  PubMed  Google Scholar 

  9. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L, CSSCD Investigators. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004;103(6):2391–6.

    Article  PubMed  CAS  Google Scholar 

  10. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605–10.

    Article  PubMed  CAS  Google Scholar 

  11. Brousse V, Hertz-Pannier L, Consigny Y, Bresson JL, Girot R, Mirre E, Lenoir G, de Montalembert M. Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease? Ann Hematol. 2009;88:785–8.

    Article  PubMed  Google Scholar 

  12. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.

    Article  PubMed  CAS  Google Scholar 

  13. Pavlakis SG, Rees RC, Huang X, Brown RC, Casella JF, Iyer RV, Kalpatthi R, Luden J, Miller ST, Rogers ZR, Thornburg CD, Wang WC, Adams RJ, BABY HUG Investigators. Transcranial Doppler ultrasound (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer. 2010;54:256–9.

    PubMed  Google Scholar 

  14. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood. 2007;110(6):2166–72.

    Article  PubMed  CAS  Google Scholar 

  15. Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol. 2007;14:191–7.

    Article  PubMed  Google Scholar 

  16. Quinn CT, Variste J, Dowling MM. Haemoglobin oxygen desaturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia. Br J Haematol. 2009;145:500–5.

    Article  PubMed  Google Scholar 

  17. Nur E, Kim YS, Truijen J, van Beers EJ, Davis SC, Brandjes DP, Biemond BJ, van Lieshout JJ. Cerebrovascular reserve capacity is impaired in patients with sickle cell disease. Blood. 2009;114(16):3473–8.

    Article  PubMed  CAS  Google Scholar 

  18. Kim YS, Nur E, van Beers EJ, Truijen J, Davis SC, Biemond BJ, van Lieshout JJ. Dynamic cerebral autoregulation in homozygous sickle cell disease. Stroke. 2009;40:808–14.

    Article  PubMed  Google Scholar 

  19. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci. 2006;27(4):204–10.

    Article  PubMed  CAS  Google Scholar 

  20. Joiner CH, Platt OS, Lux 4th SE. Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes. J Clin Invest. 1986;78:1487–96.

    Article  PubMed  CAS  Google Scholar 

  21. Rees DC, Gibson JS. Biomarkers in sickle cell disease. Br J Haematol. 2012;156(4):433–45.

    Article  PubMed  CAS  Google Scholar 

  22. Qari MH, Dier U, Mousa SA. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease. Clin Appl Thromb Hemost. 2012;18(2):195–200.

    Article  PubMed  CAS  Google Scholar 

  23. Hoppe C, Klitz W, D’Harlingue K, Cheng S, Grow M, Steiner L, Noble J, Adams R, Styles L, Stroke Prevention Trial in Sickle Cell Anemia (STOP) Investigators. Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007;38:2241–6.

    Article  PubMed  CAS  Google Scholar 

  24. Brown MD, Wick TM, Eckman JR. Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells. Pediatr Pathol Mol Med. 2001;20:47–72.

    Article  PubMed  CAS  Google Scholar 

  25. Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, Logun C, Raghavachari N, Beigel JH, Shelhamer JH, Danner RL, Gladwin MT. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood. 2004;104:270–80.

    Article  PubMed  CAS  Google Scholar 

  26. Iovannisci DM, Lammer EJ, Steiner L, Cheng S, Mahoney LT, Davis PH, Lauer RM, Burns TL. Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study. Arterioscler Thromb Vasc Biol. 2007;27:394–9.

    Article  PubMed  CAS  Google Scholar 

  27. Archer DR, Stiles JK, Newman GW, Quarshie A, Hsu LL, Sayavongsa P, Perry J, Jackson EM, Hibbert JM. C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet. J Nutr. 2008;138:1148–52.

    PubMed  CAS  Google Scholar 

  28. Hibbert JM, Hsu LL, Bhathena SJ, Irune I, Sarfo B, Creary MS, Gee BE, Mohamed AI, Buchanan ID, Al-Mahmoud A, Stiles JK. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood). 2005;230:68–74.

    CAS  Google Scholar 

  29. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ. The progression and topographic distribution of interleukin-1 beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1999;19:87–98.

    Article  PubMed  CAS  Google Scholar 

  30. Lusher JM, Haghighat H, Khalifa AS. A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am J Hematol. 1976;1:265–73.

    Article  PubMed  CAS  Google Scholar 

  31. Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W, Sarniak I, Fallon R, Chu JY, Pegelow CH, Wang W, Casella JF, Resar LS, Berman B, Adamkiewicz T, Hsu LL, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott JP, Woods GM, Watanabe M, Debaun MR. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;104:348–54.

    Google Scholar 

  32. Roach, E.S., et al. Management of stroke in infants and children. A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young. Stroke. 2008;39:2644–2691.

    Google Scholar 

  33. Management of Sickle Cell Disease. National Institutes of Health. National Heart, Lung, and Blood Institute Division of Blood Diseases and Resources, 2002.

    Google Scholar 

  34. Powars DR, Weiss JN, Chan LS, Schroeder WA. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia. Blood. 1984;63:921–6.

    PubMed  CAS  Google Scholar 

  35. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–44.

    Article  PubMed  CAS  Google Scholar 

  36. Hankins J, Aygun B. Pharmacotherapy in sickle cell disease – state of the art and future prospects. Br J Haematol. 2009;145:296–308.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA

    Justin Nolte M.D.

  2. Department of Neurosciences, MUSC Stroke Center, Medical University of South Carolina, Charleston, SC, USA

    Robert J. Adams M.D., M.S.

Authors
  1. Justin Nolte M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Adams M.D., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justin Nolte M.D. .

Editor information

Editors and Affiliations

  1. Imperial College London & Hammersmith Ho, Fulham Palace Road, London, W6 8RF, United Kingdom

    Pankaj Sharma

  2. , Mayo Clinic Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, 32224, Florida, USA

    James F Meschia

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Nolte, J., Adams, R.J. (2013). Genetics of Sickle Cell Disease and Stroke. In: Sharma, P., Meschia, J. (eds) Stroke Genetics. Springer, London. https://doi.org/10.1007/978-0-85729-209-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-209-4_9

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-208-7

  • Online ISBN: 978-0-85729-209-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation